Ultrasound-responsive catalytic microbubbles enhance biofilm elimination and immune activation to treat chronic lung infections.
Weijun XiuLili RenHuayu XiaoYue ZhangDou WangKaili YangSiyu WangLihui YuwenXiao LiHeng DongQiang LiYongbin MouYuqian ZhangZhaowei YinBin LiangYu GaoLian-Hui WangPublished in: Science advances (2023)
Efficient treatment of chronic lung infections caused by Pseudomonas aeruginosa biofilms is a great challenge because of drug tolerance and immune evasion issues. Here, we develop ultrasound-responsive catalytic microbubbles with biofilm elimination and immune activation properties to combat chronic lung infection induced by P. aeruginosa biofilms. In these microbubbles, piperacillin and Fe 3 O 4 nanoparticles form a drug-loaded shell surrounding the air core. Under ultrasound stimulation, the microbubbles can physically disrupt the structure of biofilms and enhance the penetration of both Fe 3 O 4 nanoparticles and piperacillin into the biofilm. Then, Fe 3 O 4 nanoparticles chemically degrade the biofilm matrix and kill the bacteria with the assistance of piperacillin. Fe 3 O 4 nanoparticles can activate the immune response for biofilm elimination by polarizing macrophages into a pro-inflammatory phenotype. These ultrasound-responsive catalytic microbubbles efficiently treat chronic lung infections in a mouse model by combining physical/chemical/antibiotic biofilm elimination and immune activation, thus providing a promising strategy for combating bacterial biofilm infections.
Keyphrases
- pseudomonas aeruginosa
- candida albicans
- staphylococcus aureus
- biofilm formation
- cystic fibrosis
- magnetic resonance imaging
- acinetobacter baumannii
- immune response
- cancer therapy
- mouse model
- drug induced
- drug delivery
- ultrasound guided
- emergency department
- inflammatory response
- toll like receptor
- drug resistant
- adverse drug
- electronic health record